Company Filing History:
Years Active: 2019
Title: Mourad Tighiouart: Innovator in Ovarian Cancer Research
Introduction
Mourad Tighiouart is a distinguished inventor based in Beverly Hills, CA. He has made significant contributions to the field of cancer research, particularly in understanding ovarian cancer. His innovative work focuses on developing molecular signatures that can aid in the diagnosis and treatment of this complex disease.
Latest Patents
Mourad Tighiouart holds a patent for "Molecular signatures of ovarian cancer." This patent describes gene signatures that provide prognostic, diagnostic, treatment, and molecular subtype classifications of ovarian cancers. The invention includes the generation of ovarian cancer disease signatures (OCDSs) that account for the molecular heterogeneity present in gynecological cancers. Additionally, it introduces an ovarian cancer fixed signature (OCFS) that relates to the core programming of disease development, along with an ovarian cancer stem cell (OCSC) signature. The development of various disease signatures suggests personalized treatment strategies focused on molecular subtypes of gynecological cancers, including triage tests for patients.
Career Highlights
Mourad Tighiouart is affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in cancer biology. His work has been instrumental in paving the way for more effective treatment options for patients suffering from ovarian cancer.
Collaborations
Mourad has collaborated with notable colleagues in the field, including Sandra Orsulic and Beth Y Karlan. These partnerships have enhanced the scope and impact of his research.
Conclusion
Mourad Tighiouart's innovative contributions to ovarian cancer research exemplify the importance of molecular signatures in developing personalized treatment strategies. His work not only advances scientific understanding but also holds the potential to improve patient outcomes in gynecological cancers.